Literature DB >> 8564649

The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications.

V Meunier1, M Bourrié, Y Berger, G Fabre.   

Abstract

The gastrointestinal tract remains the most popular and acceptable route of administration for drugs. It offers the great advantage of convenience and many compounds are well absorbed and thereby provide acceptable plasma concentration-time profiles. Currently there is considerable interest from the pharmaceutical industry in development of cell culture systems that would mimic the intestinal mucosa in order to evaluate strategies for investigating and/or enhancing drug absorption. The intestinal epithelial cells of primary interest, from the standpoint of drug absorption and metabolism, are the villus cells, which are fully differentiated cells. An in vitro cell culture system consisting of a monolayer of viable, polarized and fully differentiated villus cells, similar to that found in the small intestine, would be a valuable tool in the study of drug and nutrient transport and metabolism. The Caco-2 cell line, which exhibits a well-differentiated brush border on the apical surface and tight junctions, and expresses typical small-intestinal microvillus hydrolases and nutrient transporters, has proven to be the most popular in vitro model (a) to rapidly assess the cellular permeability of potential drug candidates, (b) to elucidate pathways of drug transport (e.g., passive versus carrier mediated), (c) to assess formulation strategies designed to enhance membrane permeability, (d) to determine the optimal physicochemical characteristics for passive diffusion of drugs, and (e) to assess potential toxic effects of drug candidates or formulation components on this biological barrier. Since differentiated Caco-2 cells express various cytochrome P450 isoforms and phase II enzymes such as UDP-glucuronosyltransferases, sulfotransferases and glutathione-S-transferases, this model could also allow the study of presystemic drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564649     DOI: 10.1007/bf00756522

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  52 in total

Review 1.  Improvement of drug absorption through enhancers.

Authors:  A G de Boer; E J van Hoogdalem; D D Breimer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

2.  Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs.

Authors:  P Wils; A Warnery; V Phung-Ba; D Scherman
Journal:  Cell Biol Toxicol       Date:  1994-12       Impact factor: 6.691

3.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

4.  Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption.

Authors:  L Mahraoui; A Rodolosse; A Barbat; E Dussaulx; A Zweibaum; M Rousset; E Brot-Laroche
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

5.  Caco-2 cells cultured in serum-free medium as a model for the study of enterocytic differentiation in vitro.

Authors:  C Jumarie; C Malo
Journal:  J Cell Physiol       Date:  1991-10       Impact factor: 6.384

6.  Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate.

Authors:  C Augeron; C L Laboisse
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

7.  Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells.

Authors:  A Baranczyk-Kuzma; J A Garren; I J Hidalgo; R T Borchardt
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

8.  Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

Authors:  I de Waziers; P H Cugnenc; C S Yang; J P Leroux; P H Beaune
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

9.  Isolation and characterisation of clones from the Caco-2 cell line displaying increased taurocholic acid transport.

Authors:  S Woodcook; I Williamson; I Hassan; M Mackay
Journal:  J Cell Sci       Date:  1991-03       Impact factor: 5.285

10.  Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells.

Authors:  H P Hauri; E E Sterchi; D Bienz; J A Fransen; A Marxer
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

View more
  64 in total

1.  Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than the lung epithelium in the context of acute sepsis.

Authors:  Mark W Julian; Shengying Bao; Daren L Knoell; Ruairi J Fahy; Guohong Shao; Elliott D Crouser
Journal:  Int J Exp Pathol       Date:  2011-08-13       Impact factor: 1.925

2.  Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer.

Authors:  Rakhi B Shah; Mansoor A Khan
Journal:  AAPS J       Date:  2004-10-21       Impact factor: 4.009

3.  Loss of orally administered drugs in GI tract.

Authors:  Yogeshkumar Nanasaheb Gavhane; Adhikrao Vyankatrao Yadav
Journal:  Saudi Pharm J       Date:  2012-04-20       Impact factor: 4.330

4.  Microfabrication of an asymmetric, multi-layered microdevice for controlled release of orally delivered therapeutics.

Authors:  Kristy M Ainslie; Casey M Kraning; Tejal A Desai
Journal:  Lab Chip       Date:  2008-05-16       Impact factor: 6.799

5.  A new reversible and potent P2Y12 receptor antagonist (ACT-246475): tolerability, pharmacokinetics, and pharmacodynamics in a first-in-man trial.

Authors:  Daniela Baldoni; Shirin Bruderer; Andreas Krause; Marcello Gutierrez; Pierre Gueret; Béatrice Astruc; Jasper Dingemanse
Journal:  Clin Drug Investig       Date:  2014-11       Impact factor: 2.859

6.  Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity.

Authors:  Michelle E LaFrance; Melissa A Farrow; Ramyavardhanee Chandrasekaran; Jinsong Sheng; Donald H Rubin; D Borden Lacy
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

Review 7.  The third dimension: new developments in cell culture models for colorectal research.

Authors:  Joana F S Pereira; Nikhil T Awatade; Cláudia A Loureiro; Paulo Matos; Margarida D Amaral; Peter Jordan
Journal:  Cell Mol Life Sci       Date:  2016-05-04       Impact factor: 9.261

8.  Transport of thalidomide by the human intestinal caco-2 monolayers.

Authors:  Shufeng Zhou; Yan Li; Phillip Kestell; Peter Schafer; Eli Chan; James W Paxton
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

9.  Selective assembly and functionalization of miniaturized redox capacitor inside microdevices for microbial toxin and mammalian cell cytotoxicity analyses.

Authors:  Wu Shang; Yi Liu; Eunkyoung Kim; Chen-Yu Tsao; Gregory F Payne; William E Bentley
Journal:  Lab Chip       Date:  2018-10-23       Impact factor: 6.799

Review 10.  Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.

Authors:  Chad M Thompson; Deborah M Proctor; Mina Suh; Laurie C Haws; Christopher R Kirman; Mark A Harris
Journal:  Crit Rev Toxicol       Date:  2013-03       Impact factor: 5.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.